Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livermore

Showing results (211-220 of 807) with videos related to

Pageof 81
Sort By:
Infection and Immunity|April 1, 1978
Lipid metabolism of Borrelia hermsiB P Livermore, R F Bey, R C Johnson
Antimicrobial Agents and Chemotherapy|February 1, 1984
Detection of PSE-2 beta-lactamase in enterobacteriaD M Livermore, J P Maskell, J D Williams
Human Genetics|April 7, 2017
RNA splicing and splicing regulator changes in prostate cancer pathologyJennifer Munkley, Karen Livermore, Prabhakar Rajan, et al.
International Journal of Antimicrobial Agents|May 12, 2009
Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolatesDavid M Livermore, Shazad Mushtaq, Yigong Ge, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2009
Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococciDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamasesD M Livermore, R J Williams, J D Williams
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2007
Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producersD M Livermore, R Hope, S Mushtaq, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamasesShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy|November 22, 2013
Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteriaDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2015
Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamasesDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
Pageof 81

Showing results (211-220 of 807) with videos related to

Sort By:
Pageof 81
Infection and Immunity|April 1, 1978
Lipid metabolism of Borrelia hermsiB P Livermore, R F Bey, R C Johnson
Antimicrobial Agents and Chemotherapy|February 1, 1984
Detection of PSE-2 beta-lactamase in enterobacteriaD M Livermore, J P Maskell, J D Williams
Human Genetics|April 7, 2017
RNA splicing and splicing regulator changes in prostate cancer pathologyJennifer Munkley, Karen Livermore, Prabhakar Rajan, et al.
International Journal of Antimicrobial Agents|May 12, 2009
Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolatesDavid M Livermore, Shazad Mushtaq, Yigong Ge, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2009
Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococciDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamasesD M Livermore, R J Williams, J D Williams
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2007
Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producersD M Livermore, R Hope, S Mushtaq, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamasesShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy|November 22, 2013
Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteriaDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2015
Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamasesDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
Pageof 81